LYELL IMMUNOPHARMA IN
1.1500
08-October-24 13:02:33
15 minutes delayed
Stocks
+0.0200
+1.77%
Today's range
1.1200 - 1.1698
ISIN
N/A
Source
NASDAQ
-
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
07 Jun 2023 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2023
04 May 2023 16:05:02 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in BofA Securities Healthcare Conference
02 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
28 Feb 2023 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Appoints Lynn Seely, MD as President and Chief Executive Officer
15 Dec 2022 07:00:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in BofA Securities Biotech Conference
01 Dec 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Barclays Virtual Fireside Chat Series
10 Nov 2022 16:05:01 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Recent Business Highlights and Third Quarter Financial Results
08 Nov 2022 16:05:01 By Nasdaq GlobeNewswire
-
07 Nov 2022 08:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Credit Suisse Healthcare Conference
02 Nov 2022 16:05:01 By Nasdaq GlobeNewswire
-
06 Oct 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as Chief Legal Officer
28 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Presents First in Human Trial Design of LYL797 at ESMO 2022
12 Sep 2022 03:00:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Morgan Stanley Global Healthcare Conference
30 Aug 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Second Quarter Financial Results and Business Highlights
04 Aug 2022 16:05:03 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Goldman Sachs Global Healthcare Conference
07 Jun 2022 16:05:00 By Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports First Quarter Financial Results and Business Highlights
10 May 2022 16:05:02 By Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in BofA Securities Healthcare Conference
04 May 2022 16:05:00 By Nasdaq GlobeNewswire